Omnicell OMCL is well-poised for growth in the coming quarters, backed by its continuous advancement in the Autonomous Pharmacy vision. Strong cost management across the entire organization should ...

Wells Fargo raised the firm’s price target on Omnicell (OMCL) to $52 from $43 and keeps an Overweight rating on the shares. The firm added ...

The sale represented 5.85% of direct holdings, reducing direct ownership to 98,282 shares (0.2122% of shares outstanding). All shares were sold from direct ownership; no indirect entities or ...

Healthcare tech company Omnicell (NASDAQ:OMCL) announced in Q2 CY2025, with sales up 5% year on year to $290.6 million. On top of that, next quarter’s revenue guidance ($295 million at the midpoint) ...

Mercyhealth has chosen to implement Omnicell‘s XR2 Automated Central Pharmacy System in an effort to increase its pharmacy’s efficiency and improve patient safety. The technology will be adopted at ...

Omnicell (NASDAQ:OMCL) priced $150 million principal amount of 1.00% convertible senior notes due 2029, with an option to buy an additional $22.5 million for underwriters. Omnicell plans to raise $144 ...

Omnicell is growing its portfolio of medication management solutions and adherence tools. The Mountain View, Calif.-based company has entered into a definitive agreement with pharmacy software ...

Omnicell reported that some of its information technology systems were affected by ransomware. On May 4, Omnicell, a provider of medication management and adherence tools for health systems and ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Omnicell ( (OMCL) ) has shared an update.

MOUNTAIN VIEW, Calif., Oct. 18, 2012 /PRNewswire/ -- Omnicell, Inc. (Nasdaq: OMCL) and Cerner (Nasdaq: CERN) today announced the formation of an agreement focused on interoperability between Cerner® ...

The company continues to benefit from demand for its next-generation healthcare tech offerings. Revenue for Omnicell in its third quarter amounted to $311 million, notching the company a 10% gain in ...

After a solid 2x rise since March lows of this year, at the current price of around $115 per share, Omnicell stock (NASDAQ: OMCL), a medication management services provider, has reached its near term ...